Antimicrobial use for the management of varicella in Thailand: a retrospective observational study

References

• Varicella and herpes zoster vaccines: WHO position paper. Wkly Epidemiol Rec. 2014;89(25):265–287.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Varicella. In: Epidemiology and prevention of vaccine-preventable diseases. 14th ed. Washington (DC): Public Health Foundation; 2021.
   Google Scholar
• Wolfson LJ, Castillo ME, Giglio N, et al. Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe. Hum Vaccin Immunother. 2019;15(4):932–941.
   PubMed Web of Science ®Google Scholar
• Wolfson LJ, Castillo ME, Giglio N, et al. The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe. BMC Public Health. 2019;19(1):826.
   PubMedGoogle Scholar
• Kujawski S, Casey C, Haas H, et al. Antibiotic use and economic burden of varicella infection among pediatric patients: a retrospective cohort analysis of real-world data in France (congress presentation; abstract accepted). Lisbon, Portugal: European Society for Paediatric Infectious Diseases (ESPID); 2023.
   Google Scholar
• Kujawski SA, Banks V, Casey CS, et al. Burden of antibiotic use among pediatric patients with varicella infection: a retrospective cohort analysis of real-world data in England (congress presentation). Athens, Greece: European Society for Paediatric Infectious Diseases (ESPID); 2022.
   Google Scholar
• Vandenhaute J, Tsakeu E, Chevalier P, et al. Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infect Dis. 2021;21(1):1150.
   PubMed Web of Science ®Google Scholar
• Bozzola E, Marchesani S, Ficari A, et al. Assessing the use of antibiotics in pediatric patients hospitalized for varicella. Ital J Pediatr. 2022;48(1):196.
   PubMed Web of Science ®Google Scholar
• Diniz LMO, Maia MMM, Oliveira YV, et al. Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment. Hosp Pediatr. 2018;8(7):419–425.
   PubMedGoogle Scholar
• Wutzler P, Bonanni P, Burgess M, et al. Varicella vaccination – the global experience. Expert Rev Vaccines. 2017;16(8):833–843.
   PubMed Web of Science ®Google Scholar
• Marin M, Lopez AS, Melgar M, et al. Decline in severe varicella disease during the United States varicella vaccination program: hospitalizations and deaths, 1990–2019. J Infect Dis. 2022;226(Suppl 4): s407–s415.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741.
   PubMed Web of Science ®Google Scholar
• Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–657.
   PubMed Web of Science ®Google Scholar
• Giglio N, Lasalvia P, Pawaskar M, et al. Trends in varicella burden of disease following introduction of routine childhood varicella vaccination in Argentina: a 12-year time series analysis. Vaccines. 2022;10(7):1151.
   Web of Science ®Google Scholar
• Pawaskar M, Gil-Rojas Y, Parellada CI, et al. The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: a national database analysis, 2008–2019. Vaccine. 2022;40(35):5095–5102.
   PubMed Web of Science ®Google Scholar
• Kupek E, Tritany EF. Impact of vaccination against varicella on the reduction of the disease incidence in children and adolescents from Florianópolis, Brazil. J Pediatr. 2009;85(4):365–368.
   Google Scholar
• Quian J, Rüttimann R, Romero C, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Arch Dis Child. 2008;93(10):845–850.
   PubMed Web of Science ®Google Scholar
• Elbaz M, Paret G, Yohai AB, et al. Immunisation led to a major reduction in paediatric patients hospitalised because of the varicella infection in Israel. Acta Paediatr. 2016;105(4):e161–e166.
   PubMed Web of Science ®Google Scholar
• Chao DY, Chien YZ, Yeh YP, et al. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008. Epidemiol Infect. 2012;140(6):1131–1140.
   PubMed Web of Science ®Google Scholar
• Spoulou V, Alain S, Gabutti G, et al. Implementing universal varicella vaccination in Europe: the path forward. Pediatr Infect Dis J. 2019;38(2):181–188.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Baldo V, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71.
   PubMed Web of Science ®Google Scholar
• Piazza MF, Amicizia D, Paganino C, et al. Has clinical and epidemiological varicella burden changed over time in children? Overview on hospitalizations, comorbidities and costs from 2010 to 2017 in Italy. Vaccines. 2021;9(12):1485.
   Web of Science ®Google Scholar
• Damm O, Witte J, Wetzka S, et al. Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review. Int J Public Health. 2016;61(7):847–860.
   PubMed Web of Science ®Google Scholar
• Liese JG, Cohen C, Rack A, et al. The effectiveness of varicella vaccination in children in Germany: a case-control study. Pediatr Infect Dis J. 2013;32(9):998–1004.
   PubMed Web of Science ®Google Scholar
• Pawaskar M, Fergie J, Harley C, et al. Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States. PLOS One. 2022;17(6):e0269916.
   PubMed Web of Science ®Google Scholar
• Sumpradit N, Wongkongkathep S, Malathum K, et al. Thailand’s national strategic plan on antimicrobial resistance: progress and challenges. Bull World Health Organ. 2021;99(9):661–673.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial resistance in the South-East Asia. 2022 [cited 2022 Sep 30]. Available from: https://www.who.int/thailand/health-topics/antimicrobial-resistance
   Google Scholar
• World Health Organization. Antimicrobial resistance. 2022 [cited 2022 Sep 30]. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
   Google Scholar
• Goh AEN, Choi EH, Chokephaibulkit K, et al. Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Rev Vaccines. 2019;18(5):475–493.
   PubMed Web of Science ®Google Scholar
• Ministry of Public Health-Thailand. Annual Epidemiological Surveillance Report. 2019. p. 91–94.
   Google Scholar
• Gershon AA, Marin M, Seward JF. 62 – Varicella vaccines. In: Plotkin SA, Orenstein WA, Offit PA, et al., editors. Plotkin’s vaccines. 7th ed. Philadelphia (PA): Elsevier; 2018. p. 1145.e17–1180.e17.
   Google Scholar
• Lolekha S, Tanthiphabha W, Sornchai P, et al. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg. 2001;64(3–4):131–136.
   PubMed Web of Science ®Google Scholar
• Vandepitte WP, Chanveerachai S, Srisarang S. Clinical characteristics and cost of chickenpox hospitalization in thai children. J Med Assoc Thai. 2014;97:S126–S135.
   PubMedGoogle Scholar
• Apisarnthanarak A, Kitphati R, Tawatsupha P, et al. Outbreak of varicella-zoster virus infection among Thai healthcare workers. Infect Control Hosp Epidemiol. 2007;28(4):430–434.
   PubMed Web of Science ®Google Scholar
• World Population Review. Thailand population. 2023. Available from: https://worldpopulationreview.com/countries/thailand-population
   Google Scholar
• Meszner Z, Molnar Z, Rampakakis E, et al. Economic burden of varicella in children 1–12 years of age in Hungary, 2011–2015. BMC Infect Dis. 2017;17(1):495.
   PubMedGoogle Scholar
• Wysocki J, Malecka I, Stryczynska-Kazubska J, et al. Varicella in Poland: economic burden in children 1–12 years of age in Poland, 2010-2015. BMC Public Health. 2018;18(1):410.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Chickenpox (Varicella). 2023. Available from: https://www.cdc.gov/chickenpox/hcp/index.html#high-risk-people
   Google Scholar
• Thantithaveewat T, Thananrat T, Preeyaporn V, et al. Seroprevalence of varicella-zoster antibodies in a Thai population. Southeast Asian J Trop Med. 2019;50(1):94–100.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 2022 [updated 2018 May 15]. Available from: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt17-varicella.html
   Google Scholar
• World Health Organization. Ten threats to global health in 2019. 2019. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
   Google Scholar
• Buchy P, Ascioglu S, Buisson Y, et al. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020;90:188–196.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antibiotic resistance: why vaccination is important. 2023. Available from: https://www.who.int/news-room/questions-and-answers/item/antibiotic-resistance-why-vaccination-is-important
   Google Scholar
• Gabutti G. Available evidence and potential for vaccines for reduction in antibiotic prescriptions. Hum Vaccin Immunother. 2022;18(7):2151291.
   PubMed Web of Science ®Google Scholar
• Tseng HF, Tan HF, Chang CK. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan. Southeast Asian J Trop Med Public Health. 2005;36(6):1450–1458.
   PubMedGoogle Scholar
• Lin YH, Huang LM, Chang IS, et al. Disease burden and epidemiological characteristics of varicella in Taiwan from 2000 to 2005. J Microbiol Immunol Infect. 2009;42(1):5–12.
   PubMedGoogle Scholar